Drug Shortage Report for M-M-R II
| Report ID | 103430 |
| Drug Identification Number | 00466085 |
| Brand name | M-M-R II |
| Common or Proper name | (measles, mumps and rubella virus vaccine, live, attenuated) Lyophilized powder for injection |
| Company Name | MERCK CANADA INC |
| Market Status | MARKETED |
| Active Ingredient(s) | MUMPS VIRUS VACCINE LIVE ATTENUATED RUBELLA VIRUS VACCINE LIVE ATTENUATED MEASLES VIRUS VACCINE LIVE ATTENUATED |
| Strength(s) | 5000UNIT 1000UNIT 1000UNIT |
| Dosage form(s) | POWDER FOR SOLUTION |
| Route of administration | SUBCUTANEOUS |
| Packaging size | 10X1DOSE VIAL |
| ATC code | J07BD |
| ATC description | VIRAL VACCINES |
| Reason for shortage | Delay in shipping of the drug. |
| Anticipated start date | 2020-01-16 |
| Actual start date | 2020-01-17 |
| Estimated end date | 2020-03-27 |
| Actual end date | 2020-03-20 |
| Shortage status | Resolved |
| Updated date | 2020-03-21 |
| Company comments | Remaining doses are reserved for the public immunization program. /Les doses restantes sont réservées au programme public de vaccination. |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 16750 ROUTE TRANSCANADIENNE KIRKLAND, QUEBEC CANADA H9H 4M7 |
| Company contact information | 1-800-567-2594 medinfocanada@merck.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v7 | 2020-03-21 | English | Compare |
| v6 | 2020-03-20 | English | Compare |
| v5 | 2020-01-18 | English | Compare |
| v4 | 2020-01-17 | English | Compare |
| v3 | 2020-01-17 | English | Compare |
| v2 | 2020-01-16 | French | Compare |
| v1 | 2020-01-16 | English | Compare |
Showing 1 to 7 of 7